bms 180448 has been researched along with Myocardial Ischemia in 16 studies
*Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (75.00) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, SZ; Atwal, KS; Baird, AJ; Dzwonczyk, S; Grover, GJ; Normandin, DE; Sleph, PG | 1 |
Ahmed, SZ; Atwal, KS; Dzwonczyk, S; Ferrara, FN; Grover, GJ; Harper, TW; Kim, KS; Moreland, S; Russell, AD; Sleph, PG | 1 |
Ahmed, SZ; Atwal, KS; Ding, CZ; Grover, GJ; Kelly, Y; Miller, AV; Misra, RN; Normandin, DE; Rovnyak, GC; Sleph, PG | 1 |
Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
Bogomaz, SA; Budankova, EV; Grover, GJ; Krylatov, AV; Lishmanov, AIu; Maslov, LN; Solenkova, NV | 1 |
Burkett, DE; Grover, GJ; Parham, CS; Sadanaga, KK; Scalese, RJ | 1 |
Atwal, KS; D'Alonzo, AJ; Grover, GJ; McCullough, JR; Sargent, CA | 1 |
Grover, GJ | 3 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, T; Sleph, PG | 1 |
Grover, GJ; Mitroka, JG; Parham, CS; Whigan, DB | 1 |
Grover, GJ; Sleph, PG | 1 |
D'Alonzo, AJ; Darbenzio, RB; Grover, GJ; Hess, TA; Lodge, NJ; Normandin, DE; Sewter, JC; Sleph, PG | 1 |
Behling, RW; Dzwonczyk, S; Grover, GJ; Malone, HJ; Sleph, PG | 1 |
Atwal, KS; Bajgar, R; D'Alonzo, AJ; Darbenzio, RB; Garlid, KD; Grover, GJ; Hess, TA; Lodge, NJ; Paucek, P; Sleph, PG; Smith, MA | 1 |
4 review(s) available for bms 180448 and Myocardial Ischemia
Article | Year |
---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Disease Models, Animal; Dogs; Guanidines; Guinea Pigs; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Rats; Vasodilator Agents | 1994 |
The role of ATP-sensitive potassium channels in myocardial ischemia: pharmacology and implications for the future.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Cardiotonic Agents; Disease Models, Animal; Guanidines; Humans; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyridines | 1996 |
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion.
Topics: Animals; ATP-Binding Cassette Transporters; Benzopyrans; Cromakalim; Guanidines; Humans; Ischemic Preconditioning, Myocardial; KATP Channels; Mitochondria, Heart; Models, Cardiovascular; Myocardial Ischemia; Myocardial Reperfusion; Niacinamide; Nicorandil; Picolines; Pinacidil; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyrans; Pyrroles; Rats | 1997 |
12 other study(ies) available for bms 180448 and Myocardial Ischemia
Article | Year |
---|---|
Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portion.
Topics: Adenosine Triphosphate; Animals; Guanidines; In Vitro Techniques; Magnetic Resonance Spectroscopy; Myocardial Ischemia; Potassium Channels; Rats; Structure-Activity Relationship; Vasodilator Agents | 1995 |
Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzopyrans; Biological Availability; Cocaine; Cromakalim; Guanidines; Ion Channel Gating; Molecular Structure; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Structure-Activity Relationship; Vasodilation | 1993 |
Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Glyburide; Guanidines; Heart; Muscle Contraction; Myocardial Ischemia; Potassium Channels; Rats; Vasodilation; Vasodilator Agents | 1999 |
[Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation].
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Disease Models, Animal; Guanidines; Ion Channel Gating; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Ventricular Fibrillation | 2003 |
Protective effect of mitochondrial KATP activation in an isolated gracilis model of ischemia and reperfusion in dogs.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Dogs; Female; Guanidines; Imidazoles; Male; Membrane Proteins; Myocardial Ischemia; Potassium Channels; Reperfusion | 2003 |
Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Aorta; Benzopyrans; Cromakalim; Decanoic Acids; Dogs; Female; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Ventricles; Hydroxy Acids; In Vitro Techniques; Injections, Intravenous; Injections, Subcutaneous; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1995 |
Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Female; Glyburide; Guanidines; Guinea Pigs; In Vitro Techniques; Ion Channel Gating; Male; Membrane Potentials; Myocardial Infarction; Myocardial Ischemia; Perfusion; Potassium Channels; Pyrroles; Vasodilator Agents | 1995 |
BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Dogs; Glyburide; Guanidines; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Stunning; Potassium Channels; Rats; Rats, Sprague-Dawley | 1996 |
Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cardioplegic Solutions; Cromakalim; Guanidines; Heart; Male; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley | 1995 |
A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
Topics: Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Benzopyrans; Blood Pressure; Cardiotonic Agents; Cromakalim; Dogs; Electrophysiology; Guanidines; Heart; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Species Specificity | 1995 |
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Calcium Channel Blockers; Cardiotonic Agents; Depression, Chemical; Diltiazem; Dose-Response Relationship, Drug; Glyburide; Guanidines; Heart; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardial Ischemia; Oxygen Consumption; Phosphocreatine; Potassium Channels; Rats; Rats, Sprague-Dawley | 1997 |
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Topics: Action Potentials; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Conduction System; Hydroxy Acids; Imidazoles; In Vitro Techniques; Male; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion; Papillary Muscles; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System | 2001 |